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ABSTRACT
Marfan’s syndrome is an autosomal dominant disorder of connective tissue affecting 
approximately 1 in 5000 people. In individuals with this syndrome, more than 90% of 
deaths from known causes result from cardiovascular complications, such as aortic 
dissection, aortic regurgitation, and congestive cardiac failure. In this report, we 
present a patient with a large symptomatic aortic aneurysm and chronic dissection, 
severe aortic regurgitation and cardiomegaly, treated successfully with resection of 
the proximal aorta and placement of a mechanic aortic valved graft.
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Marfan’s syndrome is an autosomal dominant disorder of connective tissue 
affecting approximately 1 in 5000 people1. In individuals with this syndrome, 
more than 90% of deaths from known causes result from cardiovascular 
complications, such as aortic dissection, aortic regurgitation, and congestive 
cardiac failure. However, advances in medical and surgical treatment have 
led to improved life expectancy. Nevertheless, as shown in the present case 
report, late diagnosis is still common, and mortality remains high2.
CASE REPORT
A 26 year-old male patient with Marfan’s syndrome was referred to the 
Cardiology outpatient clinic complaining of intermittent low cervical grip pain 
of short duration and mild to moderate intensity, unrelated to physical efforts, 
for about 6 months. Physical examination showed lateral and inferior ictus 
cordis deviation, diastolic regurgitation murmur in the left parasternal area, 
large peripheral pulses with mild amplitude reduction in right upper limb, and 
increased pulse pressure (blood pressure 113/30 mmHg).
Based on physical examination, the hypothesis of severe aortic regurgitation 
was raised, possibly with an associated aortic dissection. The patient was 
subsequently submitted to a computed tomography angiography of the 
thoracic aorta (figure  1A-C). The examination showed a thoracic aortic 
aneurysm with a maximum transverse diameter of 85 mm (ascending aorta), 
dissection extending from the aortic root to the proximal descending thoracic 
aorta (Stanford type A) and to the brachiocephalic trunk, and left ventricular 
dilatation. A transthoracic echocardiography showed left ventricular dilatation 
(end-diastolic diameter: 77 mm), borderline ejection fraction (53%), and severe 
aortic regurgitation, with a coaptation defect of the aortic cusps (figure 2A-B). 
The patient was referred to surgery, when resection of the proximal aorta 
was performed and a mechanic aortic valved graft was successfully placed. 
The patient had an uneventful recovery and was discharged on metoprolol 
tartrate and warfarin. The patient has been followed for 6 months without 
events.
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DISCUSSION
We presented a patient with Marfan´s syndrome 
with a large symptomatic aortic aneurysm and a 
most likely chronic aortic dissection, based on his 
long-term symptoms and the presence of severe aortic 
regurgitation associated with cardiomegaly. In this 
case, physical examination played a fundamental role 
in the diagnosis. Two findings in this patient strongly 




Because of the high incidence of aortic root 
aneurysm with associated risk of life-threatening aortic 
dissection, lifespan is often shortened. Before the 
successful use of surgical aortic root replacement, 
death from aortic dissection was far more common 
than it is today5. A report in the early 1970s on life 
expectancy and cause of death in Marfan’s syndrome 
describes that life expectancy for affected individuals 
was about two-thirds that of unaffected individuals6. 
Cause of death was cardiovascular (aortic dissection, 
congestive heart failure or cardiac valve disease) in over 
90% of cases. However, a more recent assessment 
of outcome in Marfan’s syndrome describes a nearly 
normal life expectancy, indicating improvement in 
the recognition and treatment of these conditions7.
Both medical and surgical therapies have improved 
life expectancy substantially up to 60-70 years. 
Figure 1: Computed tomography angiography of the thoracic aorta. A) Sagittal oblique volume-rendered image of 
the thoracic aorta showing a dilated aortic root (asterix) and the proximal  level of  the dissection flap (white arrows). 
B) Transaxial image at the level of the pulmonary artery bifurcation showing a dilated ascending aorta (asterix) and the 
dissection flap at the descending aorta (arrow). C) Three-chamber reformatted view showing a dilated ascending aorta 
(asterix) and the proximal dissection flap (arrow). Aortic aneurysm is defined as an increase of > 50% in the normal aortic 
diameter for a given age and body size3.
Figure 2: Transthoracic echocardiography images. A) Longitudinal parasternal view showing aortic root dilation (AO) 
with a dissecting flap (FLAP). B) Color Doppler apical 3-chamber view showing a severe aortic regurgitation jet (AR). 
AO = aortic root; AOV = aortic valve; LV = left ventricle; LA = left atrium.
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β-blockers might  reduce  the rate of aortic dilation 
and might improve survival, at least in adults. 
The angiotensin II receptor 1 blocker losartan is 
potentially useful because it leads to transforming 
growth factor (TGF)-β antagonism. Clinical trials are 
presently ongoing to evaluate its beneficial effect8. 
In a mouse model of Marfan’s syndrome, enhanced 
TGF-β signaling was identified and inhibition of TGF-β 
with a neutralizing antibody or with angiotensin-II 
type-1 receptor blockers was shown to reverse 
vascular complications. This result was important, 
since it provided the first new therapeutic option in 
over 20 years9. Presently, the standard of care for 
prevention of aortic complications in most centers 
remains β-blockade8.
β-adrenergic receptor blockade to delay or prevent 
aortic aneurysm and dissection is currently regarded 
as the standard of care for patients with the disorder. 
The rationale for this treatment strategy is primarily 
to decrease proximal aortic shear stress or change 
in  pressure  over  time.  β-blockers  are  probably 
beneficial  both  through  negative  inotropic  and 
negative chronotropic effects. Although small, most 
published studies have shown benefit of treatment 
with  β  blockers  in Marfan’s  syndrome5. The only 
randomized trial assessing the effect of β blockade 
in patients with the disorder was published in 1994 
by Shores et al.10, in which they describe 70 patients 
with the syndrome, and treated 32 with propranolol. 
Fewer patients treated with propranolol reached a 
primary clinical endpoint of aortic regurgitation, aortic 
dissection, cardiovascular surgery, congestive heart 
failure, and death. Furthermore, the normalized rate 
of aortic dilatation was lower in the propranolol group 
than in the control group (0.023 vs. 0.084 per year, 
p<0.001)5.
Aortic dissection, dilatation of the ascending aorta, 
and leaking aortic valve are major indications for repair 
with a composite aortic graft2. The 2014 European 
Society of Cardiology guidelines recommend surgery in 
patients with Marfan´s syndrome who have a maximal 
aortic diameter ≥ 50mm. A lower threshold of 45mm 
can be considered in patients with additional risk 
factors, including family history of dissection, size 
increase 0.3mm/year, severe aortic regurgitation, 
or desire for pregnancy9. Optimal management, 
including timing of surgery, remains debated because 
of a lack of data on aortic risk associated with 
this disease. Jondeau et al. followed 732 patients 
with Marfan’s syndrome for a mean of 6.6 years. 
Prophylactic aortic surgery was proposed when the 
maximal aortic diameter reached 50mm. Event rate 
(death/aortic dissection) was 0.17%/year. Risk rose 
with increasing aortic diameter: from 0.09%/year 
when the aortic diameter was < 40mm to 0.3% with 
diameters of 45 to 49mm and 1.33% with diameters 
of 50 to 54mm. The conclusion of this study was 
that the risk of sudden death or aortic dissection 
remains low in patients with Marfan´s syndrome and 
aortic diameter between 45 and 49mm and that an 
aortic diameter of 50mm appears to be a reasonable 
threshold for prophylactic surgery11.
Assuming that some patients will require surgical 
repair at a diameter ˂ 50mm, the question remains 
whether this indication can be better refined12. In a 
retrospective analysis, Legget et al. demonstrated 
that when body surface area (BSA) is taken into 
account, Marfan’s syndrome patients are particularly 
at risk for dissection, rupture or cardiovascular death 
when the aortic root ratio (measured diameter/
predicted  diameter)  is  ≥  1.3  (relative  risk  2.7)13. 
Although it has been suggested that aortic size be 
indexed to BSA, the problem is that patients with 
Marfan’s syndrome, particularly women, are often 
quite obese. Thus, patients in this group would 
potentially have a larger aorta before surgical repair 
was indicated. Otherwise, Svensson et al. evaluated 
whether aortic cross-sectional area indexed to 
height (r2π[cm2]/height[m]) would be of value in the 
decision of timing of surgical repair, and concluded 
that patients who present with a ratio > 10 on initial 
examination should be scheduled for an elective 
prophylactic operation, particularly because this is 
largely curative, and valve-sparing operations can 
be more frequently offered12.
After initial repair of an ascending aortic aneurysm, 
a significant number of patients have subsequent 
surgeries at other sites throughout the aorta, indicating 
that Marfan’s syndrome is a disease involving 
the entire aorta. In a study including 103 patients 
who underwent aortic aneurysm repair, 53% had 
second surgeries to repair subsequent aneurysms 
or dissections at other sites. Patients with a history 
of smoking, hypertension or who had a dissection at 
the time of the first aortic surgery were more likely 
to require subsequent aortic surgery14.
In the case reported in this paper, the high suspicion 
of severe aortic regurgitation and aortic dissection 
based on physical examination led to the diagnosis 
of the patient and subsequently to surgical treatment. 
Cases like this exemplify the fact that late diagnosis 
is common, still maintaining the high mortality of 
patients with Marfan’s syndrome, although advances 
of clinical and surgical treatment have increased the 
survival of these patients.
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